Medicine Made in Africa

Aspen Pharmacare operates some of the most advanced pharmaceutical manufacturing plants on the continent, producing medicines for both local distribution and export to more than 150 countries. The Gqeberha steriles facility is among the largest of its kind in the Southern Hemisphere, manufacturing injectable medicines used in hospitals around the world.

Aspen’s South African manufacturing footprint spans multiple facilities producing a wide range of products, from anaesthetics and antibiotics to specialised sterile injectables, supporting both domestic healthcare needs and Aspen’s position as a major pharmaceutical exporter.

“Manufacturing medicines to the highest global quality standards, right here in South Africa, is central to what we do,” says an Aspen Pharmacare spokesperson. “Our facilities support healthcare systems not just locally, but across Africa and around the world.”

A Continental Manufacturing Hub

Aspen’s Gqeberha operations have played an important role in global health supply chains, including large-scale manufacturing partnerships during international health emergencies, underscoring South Africa’s growing importance as a pharmaceutical manufacturing base for the continent.

The company continues to invest in expanding its sterile manufacturing capacity and upgrading production technology to meet rising demand for locally-made medicines.

Supporting Local Skills and Supply Chains

Aspen’s manufacturing operations support thousands of jobs directly and indirectly, from specialised pharmaceutical scientists and technicians to local packaging and logistics suppliers, strengthening South Africa’s broader life sciences manufacturing sector.

Looking Ahead

As demand for locally-manufactured medicines continues to grow across Africa, Aspen Pharmacare remains one of the continent’s flagship pharmaceutical manufacturers, anchoring Gqeberha’s status as a hub for medicine production.